ACF - End Term Paper
ACF - End Term Paper
ACF - End Term Paper
PGDM
THIRD TRIMESTER (Batch 2019-21)
END TERM EXAMINATION, APRIL-2020
1. You have to answer the questions in a separate Word Document. Your file name
should be save in following format:
Your Name_Enrollment No._Course Name
2. Do not forget to mention the following details on the first page of the word
document:
a. Enrollment Number: ________________
b. Name: ______________________
c. Course Title: ________________
d. Date: __________________
Also, frequently save your file in regular interval (15-20 minutes interval).
Second page onwards you can write your answers asked in question paper.
3. You have to upload/submit your word answer sheet in desire format using moodle
5 minutes before i.e 12:25 PM.
The submission link will be available from 11AM till 12:30PM. Only one-word
file will be allowed to upload on moodle.
4. After uploading the answer sheet on moodle, please make sure that your file has
been uploaded successful (don't leave your assignment in draft status) on moodle.
Attempt all questions
Suggestive time limit for answering each question: Q1: 25 Minutes, Q2: 20 Minutes, Q3: 15 Minutes, Case: 60
Minutes
MINI CASE
Word Limit: 400-500 words
Rajat Ltd. has spread its cosmetic business across country. This firm started its operations in 1998 and in past 22
years his sales has grown multifold. This firm had adopted strategy of organic growth.
Recently, his team identified that customers are much interested in buying herbal products. CEO of Rajat Ltd.
observed that their products are getting lot of competition from herbal products. CEO asked his CFO to adopt
aggressive approach especially through acquisitions. In this context, CFO has identified Spa herbal ltd. CFO has
looked at sales, rate of growth, operating margins, profit margin and market share.
Spa herbal is 9 year old firm with a market share of 9 percent across India and sales of 4700 million.
The financial statements of both the firms for last year is given below:
Rajat Ltd.Balance Sheet
Shareholder's Funds
(28 million shares, Rs 10 par) 3220 Fixed assets (net) 2310
Loan funds 420 Investments 350
Net current assets 980
3640 3640
Sales 6776
Profit before depreciation, interest, and taxes 1344
Depreciation 350
Profit before interest and taxes 994
Interest 56
Profit before tax 938
Tax 308
Profit after tax 630
Shareholder's Funds
(7 million shares, Rs 10 par) 910 Fixed assets (net) 658
Loan funds 350 Investments 175
Net current assets 427
1260 1260
Sales 1064
Profit before depreciation, interest, and taxes 161
Depreciation 49
Profit before interest and taxes 112
Interest 21
Profit before tax 91
Tax 24.5
Profit after tax 66.5
The market price per share of Astra Pharma is Rs.252 and the market price per share for
Magnum Drugs is Rs. 77.
(a) Calculate the exchange ratio that gives equal weightage to book value per share,
earnings per share, and market price per share.
(b) If the merger is expected to generate a synergy gain of 5 percent, what is the maximum
exchange ratio Rajat Ltd. should accept to avoid initial dilution of earnings per share?
(c) What will be the post-merger EPS of Rajat Ltd. if the exchange ratio is 1:3? Assume that
there is no synergy gain.
(d) What is the maximum exchange ratio acceptable to the shareholders of Rajat Pharma if
the PE ratio of the combined entity is 15 and there is no synergy gain?
(e) What is the minimum exchange ratio acceptable to the shareholders of Spa Herbal if the
PE ratio of the combined entity is 14 and there is a synergy benefit of 2 percent?
(f) Assuming that there is no synergy gain, at what level of the PE ratio will the lines ER 1 and
ER2 intersect?
(g) Assume that the merger is expected to generate gains which have a present value of Rs.
1000 million and the exchange ratio agreed to is 1:3. What is the true cost of the merger
from the point of view of Rajat Ltd. ?
(h) What are the limitations of earnings per share as the basis for determining the exchange
ratio?